kabutan

RaQualia Pharma, Returning to Profitability This Year

Fri Feb 14, 2025 3:45 pm JST Earnings

4579 RaQualia Pharma Inc. 【J-GAAP】

Earnings Report

RaQualia Pharma Inc. <4579> [TSE Growth] announced its financial results after the market closed on February 14th (15:45). The consolidated ordinary loss for the fiscal year ending December 2024 expanded to a loss of 361 million yen (compared to a loss of 293 million yen in the previous period). The result was better than the previously estimated deficit of loss of 476 million yen. In the fiscal year ending December 2025, the profit is expected to turn into a profit of 73 million yen.

In the most recent three-month period, from October to December (4Q), the consolidated ordinary loss improved to a deficit of 130 million yen (compared to a loss of 257 million yen in the same period last year). The operating profit/loss margin drastically improved from -56.4% in the same period last year to -25.2%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2022 2,918 866 904 723 34.5 0 Feb 14, 2023 J-GAAP
Dec, 2023 1,901 -337 -293 -323 -15.0 0 Feb 14, 2024 J-GAAP
Dec, 2024 3,107 -213 -361 -495 -22.9 0 Feb 14, 2025 J-GAAP
YoY +63.4% +36.8% -23.2% -53.3% -52.7%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 Guidance 3,135 -234 -476 -584 -26.7 0 Dec 13, 2024 J-GAAP
Dec, 2024 Results 3,107 -213 -361 -495 -22.9 0 Feb 14, 2025 J-GAAP
Revision Rate -0.9% +9.0% +24.2% +15.2% +14.5%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2024 1,411 -154 -277 -323 -15.0 0 Aug 14, 2024 J-GAAP
Jan - Jun, 2025 Guidance ー ー ー ー － 0 Feb 14, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 1,901 -337 -293 -323 -15.0 0 Feb 14, 2024 J-GAAP
Dec, 2024 3,107 -213 -361 -495 -22.9 0 Feb 14, 2025 J-GAAP
Dec, 2025 Guidance 3,888 118 73 -71 -2.9 0 Feb 14, 2025 J-GAAP
YoY +25.1% － － +85.7% +87.3%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 406 -229 -257 -206 -9.6 -56.4 Feb 14, 2024 J-GAAP
Jan - Mar, 2024 648 44 -77 -78 -3.6 6.8 May 15, 2024 J-GAAP
Apr - Jun, 2024 763 -198 -200 -245 -11.4 -26.0 Aug 14, 2024 J-GAAP
Jul - Sep, 2024 958 127 46 -16 -0.7 13.3 Nov 14, 2024 J-GAAP
Oct - Dec, 2024 738 -186 -130 -156 -7.2 -25.2 Feb 14, 2025 J-GAAP
YoY +81.8% +18.8% +49.4% +24.3% +24.5%

Related Articles